Danske Bank A S Invests $24.59 Million in Humana Inc. $HUM

Posted by Stanley Muller on Aug 20th, 2026

Danske Bank A S purchased a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 61,897 shares of the insurance provider’s stock, valued at approximately $24,587,000.

A number of other large investors have also recently modified their holdings of the company. Montag A & Associates Inc. raised its position in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new position in shares of Humana during the 4th quarter worth $27,000. Trust Co. of Vermont bought a new position in shares of Humana during the 2nd quarter worth $28,000. Reflection Asset Management purchased a new position in shares of Humana during the fourth quarter valued at $29,000. Finally, Bogart Wealth LLC increased its stake in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Down 1.3%

Shares of NYSE HUM opened at $377.18 on Thursday. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The business has a fifty day moving average price of $383.16 and a 200 day moving average price of $279.59. The stock has a market capitalization of $45.29 billion, a P/E ratio of 35.68, a price-to-earnings-growth ratio of 2.18 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74.

Humana (NYSE:HUM – Get Free Report) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.27 earnings per share. Equities research analysts expect that Humana Inc. will post 9.08 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Zacks Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Raymond James Financial lowered shares of Humana from an “outperform” rating to a “market perform” rating in a report on Thursday, July 30th. TD Cowen upped their price target on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research report on Friday, July 31st. Finally, The Goldman Sachs Group increased their price objective on shares of Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $395.22.

View Our Latest Stock Analysis on HUM

Humana Company Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Danske Bank A S Invests $24.59 Million in Humana Inc. $HUM

Humana Trading Down 1.3%

Wall Street Analysts Forecast Growth

Humana Company Profile

Further Reading

You might be interested in: